Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Number of holders
-
717
-
Total 13F shares, excl. options
-
244,532,481
-
Shares change
-
-11,405,806
-
Total reported value, excl. options
-
$11,812,873,118
-
Value change
-
-$577,754,989
-
Put/Call ratio
-
81%
-
Number of buys
-
334
-
Number of sells
-
-354
-
Price
-
$48.31
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q2 2025
835 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q2 2025.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 717 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 244,532,481 shares
of 1,226,467,754 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include Dodge & Cox (71,718,315 shares), Fisher Asset Management, LLC (13,135,366 shares), BANK OF AMERICA CORP /DE/ (9,998,529 shares), Invesco Ltd. (9,188,204 shares), Capital World Investors (8,354,084 shares), MORGAN STANLEY (8,257,646 shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (7,280,536 shares), RAYMOND JAMES FINANCIAL INC (5,879,894 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,525,745 shares), and BlackRock, Inc. (5,469,430 shares).
This table shows the top 717 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.